10Jul 2026

Antimicrobial-Resistant Neonatal Sepsis Study Begins

STUDY TO CONTAIN ANTIMICROBIAL-RESISTANT NEONATAL SEPSIS BEGINS IN INDIA Why in the News? India Joins Global Trial: India has joined the NeoSep1 international clinical trial to evaluate effective antibiotic combinations for antimicrobial-resistant neonatal sepsis, with the first participants enrolled at JIPMER, Puducherry and PGIMS, Rohtak, demonstrating strategic alignment with global health priorities. Public Health Significance: …

New Drug Offers Hope for Pancreatic Cancer

New Drug Offers Hope Against Pancreatic Cancer Why in the News ? A new oral drug called Daraxonrasib has shown promising results in patients with advanced pancreatic cancer, nearly doubling survival time in clinical trials. The breakthrough highlights the growing role of precision medicine in treating difficult-to-cure cancers. Daraxonrasib and Breakthrough in Pancreatic Cancer Treatment: …

WHO Declares Mpox No Longer Global Emergency

WHO Declares Mpox No Longer Global Emergency Why in the News ? The World Health Organization (WHO) has announced that Mpox is no longer a Public Health Emergency of International Concern (PHEIC) after a steady decline in cases across Africa, particularly in the Democratic Republic of Congo and neighbouring countries. Recent Developments on Mpox Outbreak: …

Tag

Antimicrobial-Resistant Neonatal Sepsis Study Begins

New Drug Offers Hope for Pancreatic Cancer

WHO Declares Mpox No Longer Global Emergency

Two Mega Events, One Extraordinary Platform at Universal Green School